萬潤科技(002654.SZ):擬設立全資子公司負責先進存儲模組製造項目的建設
格隆匯8月8日丨萬潤科技(002654.SZ)公佈,爲落實大力發展以半導體電子產業爲核心的新一代信息技術“主產業”戰略,擴大主業經營規模,提高盈利水平,公司自籌資金設立全資子公司深圳萬潤存儲科技有限公司(簡稱“萬潤存儲”),註冊資本人民幣1億元,負責先進存儲模組製造項目的建設。
萬潤存儲將在深圳市光明區萬潤大廈建設先進存儲模組製造項目,根據市場情況進行存儲模組產品的生產和銷售,通過購置先進的自動化存儲模組生產和測試設備,構建自主存儲模組生產和測試能力,高效滿足市場和客戶需求,擴大市場份額,提高盈利水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.